Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 8Pain 6Breast Neoplasms 6Prostatic Neoplasms 5Pain, Postoperative 4Neuralgia 4Lung Neoplasms 4Keratosis, Actinic 4Agnosia 4Neoplasms 3Myofibroma 2Leiomyoma 2Inflammatory Bowel Diseases 2Diverticulitis 2Colonic Neoplasms 2Cancer Pain 2Uterine Neoplasms 1Tuberculosis 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Stomatitis 1Stomach Neoplasms 1Scleroderma, Localized 1Sarcoidosis 1Prostate Biopsy 1Peripheral Nervous System Diseases 1Pelvic Neoplasms 1Patient Satisfaction 1Paget Disease, Extramammary 1Ovarian Cysts 1

Interventions

Sorafenib 42Bevacizumab 16Oxaliplatin 13Radiosurgery 10Gemcitabine 10Doxorubicin 10Capecitabine 10Leucovorin 9Hepatectomy 9Fluorouracil 9Cisplatin 9Radiofrequency Ablation 8Nivolumab 8pembrolizumab 7Drug Therapy 7Carboplatin 7Irinotecan 6Cryosurgery 6Talaporfin 5Mitomycin 5Everolimus 5Erlotinib Hydrochloride 5Electroporation 5spartalizumab 4Sunitinib 4Melphalan 4Ipilimumab 4Epirubicin 4Embolization, Therapeutic 4regorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Liver Neoplasms × Lidocaine × Clear all
NCT05153785 2026-01-15

Perioperative Intravenous Lidocaine in Liver Surgery

Lund University Hospital

Phase 2/3 Completed
124 enrolled
Gastrointestinal

Liver Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡